PR Newswire (press release)MilliporeSigma Develops Alternative CRISPR Genome Editing MethodPR Newswire (press release)BILLERICA, Mass., May 17, 2017 /PRNewswire/ — MilliporeSigma today has developed a new genome editing tool that makes CRISPR more eff… Continue reading
MilliporeSigma Develops Alternative CRISPR Genome Editing MethodCanada NewsWire (press release)BILLERICA, Mass., May 17, 2017 /CNW/ — MilliporeSigma today has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific,… Continue reading
Pharmaceutical Processing |
Allergy Shots for Bee Stings No Longer Sufficient: Time for Customized Immunotherapy?
Pharmaceutical Processing This is where allergen-specific immunotherapy, commonly known as allergy shots, can help. The treatment involves injecting very small doses of the venom under the patient’s skin. The idea is to force the body to become accustomed to the poison and … |
PharmaTimes |
FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
PharmaTimes US regulators have granted a Fast Track designation to a potential gene therapy treatment for haemophilia A from Pfizer and Sangamo. SB-525, which also has orphan drug status from the FDA, is one of Sangamo’s four lead candidates and is expected to … |
CBS New York |
Seen At 11: Promising Treatment Uses Patient’s Immune System To Fight Cancer
CBS New York Better yet, some of the CAR T-Cells may actually stick around to fight a recurrence, Dr. Hunger explained. “A one-time treatment can certainly lead to at least five years of survival, and we hope can lead to cures,” Dr. Hunger said. After battling … |